Cargando…
Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3
INTRODUCTION: Metastasis is a common event and the main cause of death in cancer patients. Lymphangiogenesis refers to the formation of new lymphatic vessels and is thought to be involved in the development of metastasis. Sunitinib is a multi-kinase inhibitor that blocks receptor tyrosine kinase act...
Autores principales: | Kodera, Yasuo, Katanasaka, Yasufumi, Kitamura, Yuka, Tsuda, Hitoshi, Nishio, Kazuto, Tamura, Tomohide, Koizumi, Fumiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218955/ https://www.ncbi.nlm.nih.gov/pubmed/21693010 http://dx.doi.org/10.1186/bcr2903 |
Ejemplares similares
-
Epidermal growth factor receptor variant type III markedly accelerates angiogenesis and tumor growth via inducing c-myc mediated angiopoietin-like 4 expression in malignant glioma
por: Katanasaka, Yasufumi, et al.
Publicado: (2013) -
Tolerogenic Properties of Lymphatic Endothelial Cells Are Controlled by the Lymph Node Microenvironment
por: Cohen, Jarish N., et al.
Publicado: (2014) -
Sunitinib but not VEGF blockade inhibits cancer stem cell endothelial differentiation
por: Brossa, Alessia, et al.
Publicado: (2015) -
The Lymphatic Endothelial mCLCA1 Antibody Induces Proliferation and Growth of Lymph Node Lymphatic Sinuses
por: Jordan-Williams, Kimberly L., et al.
Publicado: (2016) -
A critical role for lymphatic endothelial heparan sulfate in lymph node metastasis
por: Yin, Xin, et al.
Publicado: (2010)